rhenium-186 HEDP

Subscribe to Selected New Research on rhenium-186 HEDP

19 relevant articles (5 outcomes, 5 trials/studies) found for this Bio-Agent

Description: used as a complement to analgesic therapy in patients with painful disseminated bone metastases

Also Known As:

(186Re)-hydroxyethylidene diphosphonate; 186Re HEDP; rhenium-188 HEDP; rhenium-188 hydroxyethylidene diphosphonate; rhenium-hydroxyethylidene diphosphonate

Relationship Network

Bio-Agent Context: Research Results

Organic Chemicals: 40

Organophosphorus Compounds: 126

Diphosphonates: 2715

Etidronic Acid: 706

rhenium-186 HEDP: 19

Organometallic Compounds: 5

rhenium-186 HEDP: 19

Experts

1.	Minutoli, F: 1 article (12/2006)
2.	Aricò, D: 1 article (12/2006)
3.	Restifo Pecorella, G: 1 article (12/2006)
4.	Spadaro, P: 1 article (12/2006)
5.	Altavilla, G: 1 article (12/2006)
6.	Baldari, S: 1 article (12/2006)
7.	Herberg, A: 1 article (12/2006)
8.	Derejko, Mirosława: 1 article (01/2003)
9.	Bandurski, Tomasz: 1 article (01/2003)
10.	Romanowicz, Grzegorz: 1 article (01/2003)

Related Diseases

1.	Pain (Aches) 08/01/2003 - "The aim of this study was to determine the pain palliation and the antitumor effect of rhenium-188 HEDP treatments" 08/01/2003 - "The effectiveness of rhenium-188 HEDP for pain palliation was better in the repeated treatment group (group B), with a response rate and time of response of 92% and 5.66 months, respectively (P =.006 and P =.001)" 05/07/2000 - "Rhenium-188 hydroxyethylidene diphosphonate (Re-188 HEDP) is a new radiopharmaceutical for treatment of metastatic bone pain" 05/07/2000 - "Clinical experience with rhenium-188 HEDP therapy for metastatic bone pain]" 11/01/2000 - "Significant reduction of the mass of bone metastasis 1 year after rhenium-186 HEDP pain palliation therapy." Get all the results and reference details, order at left...
2.	Neoplasm Metastasis (Metastasis) 01/01/2003 - "This paper reviews the application of rhenium-188 HEDP as a reactor- or generator-produced nuclide for bone metastases therapy." 01/01/2003 - "Application of rhenium-188 HEDP in bone metastases therapy." 11/01/2001 - "Rhenium-188 HEDP to treat painful bone metastases." 10/01/1997 - "Rhenium-186 HEDP: palliative radionuclide therapy of painful bone metastases" 06/01/1997 - "Rhenium-188 hydroxyethylidene diphosphonate: a new generator-produced radiotherapeutic drug of potential value for the treatment of bone metastases." Get all the results and reference details, order at left...
3.	Breast Neoplasms (Breast Cancer) 01/01/1998 - "As conclusion we found out that therapy with rhenium-186 HEDP can be used complementarily to analgesic therapy and radiation in patients with painful disseminated bone metastases in breast cancer." 01/01/1998 - "The aim of this study was to evaluate the efficacy of rhenium-186 HEDP for pain palliation in patients with bone metastases in breast cancer" 09/01/1999 - "Pain palliation with rhenium-186 HEDP in breast cancer patients with disseminated bone metastases." 08/01/2007 - "In total, 79 patients (18 with breast cancer and 61 with prostate cancer) were treated (31 patients with 188Re-HEDP, 15 patients each with 186Re-HEDP and 153Sm-EDTMP, and 18 patients with 89Sr)" Get all the results and reference details, order at left...
4.	Carcinoma (Carcinomatosis) 11/01/1999 - "Visualization of the stomach on rhenium-186 HEDP imaging after therapy for metastasized prostate carcinoma." 08/01/2003 - "CONCLUSION: Compared with single-injection therapy, repeated bone-targeted therapy with rhenium-188 HEDP administered to patients with advanced progressive hormone-refractory prostate carcinoma enhanced pain palliation and improved progression-free and overall survival" Get all the results and reference details, order at left...
5.	Neoplasms (Cancer) 12/01/2006 - "Whereas, to the best of our knowledge, only few cases of bone metastases from tumors other than prostate and breast treated with [186Re]HEDP have been reported" 12/01/2006 - "186Re]HEDP in the palliation of painful bone metastases from cancers other than prostate and breast." 12/01/2006 - "CONCLUSIONS: Pain palliation with [186Re]HEDP seems highly effective and safe also in patients with bone metastases from cancers other than prostate and breast" Get all the results and reference details, order at left...
8 Diseases and 19 more articles analyzed in the Research Interface, order at left...

Related Drugs and Biologics

1.	Hormones
2.	Etidronic Acid (HEDP)
3.	Analgesics (Analgesic Drugs)
4.	Radioisotopes (Radionuclides)
5.	Pentetic Acid (DTPA)
5 Drugs and Important Bio-Agents and 8 more articles analyzed in the Research Interface, order at left...

Related Therapies and Procedures

1.	Radiotherapy
1 Therapies and Procedures and 1 more articles analyzed in the Research Interface, order at left...

Research Interface

Rapidly retrieve summaries of all the evidence for any disease in seconds. Save hours of search and analysis time. CureHunter is unlike any "search engine" you have ever used. Where standard "search engines" produce lists of links, CureHunter quantifies evidence, extracts it from the literature and calculates a result you can use to immediately facilitate evidence based decision making in Real Clinical Time.

Unlimited Disease, Drug and Therapy Search
2 clicks from Disease to Drug to Evidence
Trial References
All the Positive Outcomes
Detailed Relationship Timeline Charts
Full Article Reference Details
Includes Mobile Interface Subscription
One-click to FDA Products/Patents
Request Institution License details >>

Price:

$490.00 access via web interface, 1 year subscription

Proceed to Checkout >>

Mobile Interface

Retrieve summaries of all the evidence for any disease from your Mobile Phone or PDA. Accelerate decision making in the field. Speed up your study of new drug and disease domains. Refresh your knowledge on the road.

Access from any web enabled PDA or Phone
Trial references
All the Positive Outcomes
Drug and Therapy searches
Full Article Reference Details
Try Mobile Interface >>

Price:

$45.00 access via "curehunter.com/m", 1 year subscription

Proceed to Checkout >>